Preoperative Carcinoembryonic Antigen is Related to Tumour Stage and Long-term Survival in Colorectal Cancer

Overview

Journal Br J Cancer

Specialty Oncology

Date 1998 Nov 21

PMID 9823977

Citations 23

Authors

M A Chapman

D Buckley

D B Henson

N C Armitage

Affiliations

Soon will be listed here.

Abstract

Evidence as to the value of preoperative carcinoembryonic antigen (CEA) in guiding treatment for patients with colorectal cancer is conflicting. The aim of this prospective study was to investigate the value of preoperative CEA in predicting tumour factors of proven prognostic value and long-term survival in patients undergoing surgery for colorectal cancer. Preoperative serum CEA, tumour ploidy, stage and grade were ascertained in 277 patients undergoing colorectal cancer surgery. This cohort of patients were followed up for a minimum of 5 years, or until death, in a dedicated colorectal clinic. Patients with an elevated CEA had a 5 year survival of 39%. This increased to 57% if the CEA was normal (P=0.001). The proportion of patients with a raised CEA increased with a more advanced tumour stage (P < 0.000001) and a poorly differentiated tumour grade (P < 0.005). Once stage had been controlled for, CEA was not a predictor of survival. No relationship between tumour ploidy and CEA was found. In conclusion, a raised preoperative serum CEA is likely to be associated with advanced tumour stage and poor long-term survival, compared with patients with a normal value.

Citing Articles

Identifying timing and risk factors for early recurrence of resectable rectal cancer: A single center retrospective study.

Tsai T, Syu K, Huang X, Liu Y, Chen C, Wu Y World J Gastrointest Surg. 2024; 16(9):2842-2852.

PMID: 39351564 PMC: 11438806. DOI: 10.4240/wjgs.v16.i9.2842.

Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update.

Chang K, Jiang L, Sun Y, Li H Mol Diagn Ther. 2022; 26(4):397-409.

PMID: 35732878 DOI: 10.1007/s40291-022-00593-3.

Predictive factors associated with relapse of stage II/III colon cancer treated with peroral anti-cancer agents in the adjuvant setting.

Mizuuchi Y, Tanabe Y, Sada M, Kitaura Y, Nagai S, Watanabe Y Mol Clin Oncol. 2021; 14(6):122.

PMID: 33936595 PMC: 8082226. DOI: 10.3892/mco.2021.2284.

Initial experience of preoperative short-course radiotherapy followed by oxaliplatin-based consolidation chemotherapy for locally advanced rectal cancer.

Song S, Park J, Kang M, Choi G, Park S, Kim H Int J Colorectal Dis. 2021; 36(6):1279-1286.

PMID: 33547945 DOI: 10.1007/s00384-021-03875-0.

Prognostic value of carcinoembryonic antigen levels before and after curative surgery in colon cancer patients.

Kim H, Joo J, Lim S, Oh B Ann Surg Treat Res. 2021; 100(1):33-39.

PMID: 33457395 PMC: 7791194. DOI: 10.4174/astr.2021.100.1.33.

References

Goslin R, Steele Jr G, Macintyre J, Mayer R, Sugarbaker P, Cleghorn K . The use of preoperative plasma CEA levels for the Stratification of patients after curative resection of colorectal cancers. Ann Surg. 1980; 192(6):747-51. PMC: 1344975. DOI: 10.1097/00000658-198012000-00010. View

Wanebo H, Rao B, Pinsky C, Hoffman R, Stearns M, Schwartz M . Preoperative carcinoembryonic antigen level as a prognostic indicator in colorectal cancer. N Engl J Med. 1978; 299(9):448-51. DOI: 10.1056/NEJM197808312990904. View

MOERTEL C, OFallon J, Go V, Oconnell M, Thynne G . The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer. 1986; 58(3):603-10. DOI: 10.1002/1097-0142(19860801)58:3<603::aid-cncr2820580302>3.0.co;2-k. View

Williams N, Jass J, Hardcastle J . Clinicopathological assessment and staging of colorectal cancer. Br J Surg. 1988; 75(7):649-52. DOI: 10.1002/bjs.1800750710. View

Armitage N, Ballantyne K, Sheffield J, Clarke P, Evans D, Hardcastle J . A prospective evaluation of the effect of tumor cell DNA content on recurrence in colorectal cancer. Cancer. 1991; 67(10):2599-604. DOI: 10.1002/1097-0142(19910515)67:10<2599::aid-cncr2820671033>3.0.co;2-6. View

Kouri M, Pyrhonen S, Mecklin J, Jarvinen H, Laasonen A, Franssila K . Serum carcinoembryonic antigen and DNA ploidy in colorectal carcinoma. A prospective study. Scand J Gastroenterol. 1991; 26(8):812-8. DOI: 10.3109/00365529109037017. View

Filella X, Molina R, Grau J, Pique J, Garcia-Valdecasas J, Astudillo E . Prognostic value of CA 19.9 levels in colorectal cancer. Ann Surg. 1992; 216(1):55-9. PMC: 1242546. DOI: 10.1097/00000658-199207000-00008. View

Wang J, Tang R, Chiang J . Value of carcinoembryonic antigen in the management of colorectal cancer. Dis Colon Rectum. 1994; 37(3):272-7. DOI: 10.1007/BF02048166. View

Filella X, Molina R, Pique J, Grau J, Garcia-Valdecasas J, Biete A . CEA as a prognostic factor in colorectal cancer. Anticancer Res. 1994; 14(2B):705-8. View

10.

Eskelinen M, Pasanen P, Kulju A, Janatuinen E, Miettinen P, Poikolainen E . Clinical evaluation of serum tumour markers CEA, CA 50 and CA 242 in colorectal cancer. Anticancer Res. 1994; 14(3B):1427-32. View

11.

McCall J, BLACK R, Rich C, Harvey J, Baker R, Watts J . The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum. 1994; 37(9):875-81. DOI: 10.1007/BF02052591. View

12.

Tsuchiya A, Ando Y, Kikuchi Y, Kanno M, Sato H, Yoshida T . Reappraisal of preoperative carcinoembryonic antigen levels as a prognostic factor in resectable colorectal cancer. Fukushima J Med Sci. 1994; 40(1):9-17. View

13.

Diez M, Cerdan F, Pollan M, Maestro M, Ortega M, Martinez S . Prognostic significance of preoperative serum CA 19.9 assay in patients with colorectal carcinoma. Anticancer Res. 1994; 14(6B):2819-25. View

14.

Lindmark G, Bergstrom R, Pahlman L, Glimelius B . The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer. Br J Cancer. 1995; 71(5):1090-4. PMC: 2033799. DOI: 10.1038/bjc.1995.211. View

15.

Northover J . The use of prognostic markers in surgery for colorectal cancer. Eur J Cancer. 1995; 31A(7-8):1207-9. DOI: 10.1016/0959-8049(95)00158-f. View

16.

Chapman M, Hardcastle J, Armitage N . Five-year prospective study of DNA tumor ploidy and colorectal cancer survival. Cancer. 1995; 76(3):383-7. DOI: 10.1002/1097-0142(19950801)76:3<383::aid-cncr2820760306>3.0.co;2-f. View

17.

Takahashi T, Kato T, Kodaira S, Koyama Y, Sakabe T, Tominaga T . Prognostic factors of colorectal cancer. Results of multivariate analysis of curative resection cases with or without adjuvant chemotherapy. Am J Clin Oncol. 1996; 19(4):408-15. DOI: 10.1097/00000421-199608000-00019. View

18.

Vauthey J, Dudrick P, Lind D, Copeland 3rd E . Management of recurrent colorectal cancer: another look at carcinoembryonic antigen-detected recurrence. Dig Dis. 1996; 14(1):5-13. DOI: 10.1159/000171535. View

19.

Gold P, Freedman S . Specific carcinoembryonic antigens of the human digestive system. J Exp Med. 1965; 122(3):467-81. PMC: 2138078. DOI: 10.1084/jem.122.3.467. View

20.

Lewi H, Blumgart L, Carter D, Gillis C, Hole D, Ratcliffe J . Pre-operative carcino-embryonic antigen and survival in patients with colorectal cancer. Br J Surg. 1984; 71(3):206-8. DOI: 10.1002/bjs.1800710312. View